抗体-药物结合的不良影响可以根据免疫复杂清除机制来理解和解决
Ronald P Taylor1, Margaret A Lindorfer1
1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA.
在癌症治疗中,抗体-药物联合体 (ADC) 的不良副作用可能源于免疫复杂处理途径. 了解Fcγ受体相互作用可以帮助预测和减轻这些严重的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 在癌症免疫治疗中至关重要,有几种FDA批准的药物.
- 尽管有效,但ADCs可能会在一些患者中引起严重的不良副作用 (ASEs).
研究的目的:
- 通过免疫复杂路径进行不适当的处理解释了与ADC相关的严重ASEs.
- 通过了解ADC-Fcγ受体相互作用,提供最小化ASEs的理由.
主要方法:
- 发表的基础科学实验和临床观察的审查.
- 对非目标细胞和组织上的Fcγ受体相互作用的分析.
- 专注于FDA批准的ADCs:gemtuzumab臭胺,inotuzumab臭胺,trastuzumab埃姆坦辛和trastuzumab德鲁克斯泰康.
主要成果:
- 假设ADC的细胞和细胞有助于病理.
- 确定Fcγ受体相互作用是ADC中介毒性的关键机制.
- 建议进行特定测量以识别有风险的患者.
结论:
- 了解通过免疫复杂途径处理ADC对于管理ASEs至关重要.
- 针对Fcγ受体相互作用提供了一种减少ADC相关毒性的策略.
- 拟议的方法和治疗旨在提高ADC在癌症治疗中的安全性.
更多相关视频
09:54Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
05:21Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
相关概念视频
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Drug Elimination: The Concept of Clearance
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Phase II Conjugation Reactions: Overview
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Drug Clearance: Overview
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Cross-reactivity
